PCK2 and ovarian carcinoma: In addition, through the literature review, we found that except CYBB, VDAC2, IDH1, MT1G, SLC1A4, PCK2, SLC3A2, the prognostic value of other FRGs in ovarian cancer has been reported, which provided a possibility for constructing a prognostic model.